TG THERAPEUTICS, INC. Licenses Revenue (Deprecated 2018-01-31)
TG THERAPEUTICS, INC. (TGTX) reported Licenses Revenue (Deprecated 2018-01-31) of $38.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2018-05-10
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $38.00K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $38.09K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $38.10K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $38.09K, a 0.00% change year-over-year.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2017 was $152.38K, a 0.00% change from fiscal 2016.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2016 was $152.38K, a 0.00% change from fiscal 2015.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2015 was $152.38K, a 0.00% change from fiscal 2014.
- TG THERAPEUTICS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2014 was $152.38K, a 0.00% change from fiscal 2013.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 3 month as first filed | Licenses Revenue (Deprecated 2018-01-31) 6 month | Licenses Revenue (Deprecated 2018-01-31) 9 month | Licenses Revenue (Deprecated 2018-01-31) 12 month | Licenses Revenue (Deprecated 2018-01-31) 13 month | Licenses Revenue (Deprecated 2018-01-31) 16 month | Licenses Revenue (Deprecated 2018-01-31) 19 month | Licenses Revenue (Deprecated 2018-01-31) 22 month | Licenses Revenue (Deprecated 2018-01-31) 25 month | Licenses Revenue (Deprecated 2018-01-31) 28 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $38.00K 10-Q · filed 2018-05-10 | $76.09K derived: sum of 2 quarters · filed 2018-05-10 | $114.19K derived: sum of 3 quarters · filed 2018-05-10 | $152.29K derived: sum of 4 quarters · filed 2018-05-10 | |||||||
| 2017-12-31 | $38.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K 10-K · filed 2018-03-15 | |||||||
| 2017-09-30 | $38.10K 10-Q · filed 2017-11-09 | $76.19K derived: sum of 2 quarters · filed 2017-11-09 | $114.29K 10-Q · filed 2017-11-09 | $152.29K derived: sum of 4 quarters · filed 2018-05-10 | |||||||
| 2017-06-30 | $38.09K 10-Q · filed 2017-08-09 | $76.19K 10-Q · filed 2017-08-09 | $114.19K derived: sum of 3 quarters · filed 2018-05-10 | $152.29K derived: sum of 4 quarters · filed 2018-05-10 | |||||||
| 2017-03-31 | $38.00K 10-Q · filed 2018-05-10 | $38.09K 10-Q · filed 2017-05-10 | $76.09K derived: sum of 2 quarters · filed 2018-05-10 | $114.19K derived: sum of 3 quarters · filed 2018-05-10 | $152.29K derived: sum of 4 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | $38.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K 10-K · filed 2018-03-15 | |||||||
| 2016-09-30 | $38.10K 10-Q · filed 2017-11-09 | $76.19K derived: sum of 2 quarters · filed 2017-11-09 | $114.29K 10-Q · filed 2017-11-09 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 | |||||||
| 2016-06-30 | $38.09K 10-Q · filed 2017-08-09 | $76.19K 10-Q · filed 2017-08-09 | $114.28K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 | |||||||
| 2016-03-31 | $38.09K 10-Q · filed 2017-05-10 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K derived: sum of 4 quarters · filed 2018-03-15 | |||||||
| 2015-12-31 | $38.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $76.19K derived: sum of 2 quarters · filed 2018-03-15 | $114.29K derived: sum of 3 quarters · filed 2018-03-15 | $152.38K 10-K · filed 2018-03-15 | |||||||
| 2015-09-30 | $38.10K 10-Q · filed 2016-11-09 | $76.19K derived: sum of 2 quarters · filed 2016-11-09 | $114.29K 10-Q · filed 2016-11-09 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-06-30 | $38.09K 10-Q · filed 2016-08-09 | $76.19K 10-Q · filed 2016-08-09 | $114.28K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-03-31 | $38.09K 10-Q · filed 2016-05-10 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.29K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2014-12-31 | $38.09K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $76.19K derived: sum of 2 quarters · filed 2017-03-16 | $114.29K derived: sum of 3 quarters · filed 2017-03-16 | $152.38K 10-K · filed 2017-03-16 | |||||||
| 2014-09-30 | $38.10K 10-Q · filed 2015-11-09 | $76.19K derived: sum of 2 quarters · filed 2015-11-09 | $114.29K 10-Q · filed 2015-11-09 | $152.38K derived: sum of 4 quarters · filed 2016-03-15 | |||||||
| 2014-06-30 | $38.09K 10-Q · filed 2015-08-10 | $76.19K 10-Q · filed 2015-08-10 | $114.28K derived: sum of 3 quarters · filed 2016-03-15 | $152.38K derived: sum of 4 quarters · filed 2016-03-15 | |||||||
| 2014-03-31 | $38.09K 10-Q · filed 2015-05-11 | $76.19K derived: sum of 2 quarters · filed 2016-03-15 | $114.29K derived: sum of 3 quarters · filed 2016-03-15 | $152.38K derived: sum of 4 quarters · filed 2016-03-15 | $209.52K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $38.09K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $76.19K derived: sum of 2 quarters · filed 2016-03-15 | $114.29K derived: sum of 3 quarters · filed 2016-03-15 | $152.38K 10-K · filed 2016-03-15 | $171.43K 10-K · filed 2014-03-07 | ||||||
| 2013-09-30 | $38.10K 10-Q · filed 2014-11-14 | $76.19K derived: sum of 2 quarters · filed 2014-11-14 | $114.29K 10-Q · filed 2014-11-14 | $133.33K derived: sum of 4 quarters · filed 2014-11-14 | $133.33K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $38.09K 10-Q · filed 2014-07-24 | $76.19K 10-Q · filed 2014-07-24 | $95.24K derived: sum of 3 quarters · filed 2014-07-24 | $95.24K derived: sum of 4 quarters · filed 2014-07-24 | $95.24K 10-Q · filed 2013-08-09 | ||||||
| 2013-03-31 | $38.09K 10-Q · filed 2014-05-14 | $57.14K derived: sum of 2 quarters · filed 2014-05-14 | $57.14K derived: sum of 3 quarters · filed 2014-05-14 | $57.14K derived: sum of 4 quarters · filed 2014-05-14 | $57.14K 10-Q · filed 2013-05-14 | ||||||
| 2012-12-31 | $19.05K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $19.05K derived: sum of 2 quarters · filed 2014-03-07 | $19.05K derived: sum of 3 quarters · filed 2014-03-07 | $19.05K 10-K · filed 2014-03-07 | $19.05K 10-K · filed 2013-03-21 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | |||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | ||||||||||
| 2011-12-31 | $0.00 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |